Skip to main content
Erschienen in:

26.11.2018 | What's New in Intensive Care

What’s new in the prevention of healthcare-associated infections using chlorhexidine gluconate-impregnated washcloths

verfasst von: Sandrine Dray, Jean-Marie Forel, Laurent Papazian

Erschienen in: Intensive Care Medicine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Auszug

Critically ill patients hospitalized in intensive care units (ICUs) are at high risk for health care-associated infections (HAIs) in relation to their underlying conditions, comorbidities, impaired host defences, and the placement of invasive devices (endotracheal tubes, bladder catheters, and intravascular devices including catheters). These HAIs include surgical site infections, central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonias (VAPs), and bloodstream infections. HAIs are strongly associated with prolonged length of stay, increased mortality and increased costs. In addition, the number of infections related to multidrug resistant organisms (MDROs) is increasing and is associated with a limited number of effective antimicrobial drugs. Many of these organisms such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae colonize the skin of hospitalized patients. …
Literatur
1.
Zurück zum Zitat Ruiz J, Ramirez P, Villarreal E, Gordon M, Saez I, Rodriguez A, Castaneda MJ, Castellanos-Ortega A (2017) Daily bathing strategies and cross-transmission of multidrug-resistant organisms: impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit. Am J Infect Control 45:1069–1073CrossRefPubMed Ruiz J, Ramirez P, Villarreal E, Gordon M, Saez I, Rodriguez A, Castaneda MJ, Castellanos-Ortega A (2017) Daily bathing strategies and cross-transmission of multidrug-resistant organisms: impact of chlorhexidine-impregnated wipes in a multidrug-resistant gram-negative bacteria endemic intensive care unit. Am J Infect Control 45:1069–1073CrossRefPubMed
2.
Zurück zum Zitat Lin MY, Lolans K, Blom DW, Lyles RD, Weiner S, Poluru KB, Moore N, Hines DW, Weinstein RA, Hayden MK, Centers for Disease C, Prevention Epicenter P (2014) The effectiveness of routine daily chlorhexidine gluconate bathing in reducing klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol 35:440–442CrossRefPubMed Lin MY, Lolans K, Blom DW, Lyles RD, Weiner S, Poluru KB, Moore N, Hines DW, Weinstein RA, Hayden MK, Centers for Disease C, Prevention Epicenter P (2014) The effectiveness of routine daily chlorhexidine gluconate bathing in reducing klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae skin burden among long-term acute care hospital patients. Infect Control Hosp Epidemiol 35:440–442CrossRefPubMed
3.
Zurück zum Zitat Edmiston CE Jr, Seabrook GR, Johnson CP, Paulson DS, Beausoleil CM (2007) Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control 35:89–96CrossRefPubMed Edmiston CE Jr, Seabrook GR, Johnson CP, Paulson DS, Beausoleil CM (2007) Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery. Am J Infect Control 35:89–96CrossRefPubMed
4.
Zurück zum Zitat Rhee Y, Palmer LJ, Okamoto K, Gemunden S, Hammouda K, Kemble SK, Lin MY, Lolans K, Fogg L, Guanaga D, Yokoe DS, Weinstein RA, Frendl G, Hayden MK, Centers for Disease C, Prevention Epicenter P (2018) Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery. Infect Control Hosp Epidemiol 39:405–411CrossRefPubMed Rhee Y, Palmer LJ, Okamoto K, Gemunden S, Hammouda K, Kemble SK, Lin MY, Lolans K, Fogg L, Guanaga D, Yokoe DS, Weinstein RA, Frendl G, Hayden MK, Centers for Disease C, Prevention Epicenter P (2018) Differential effects of chlorhexidine skin cleansing methods on residual chlorhexidine skin concentrations and bacterial recovery. Infect Control Hosp Epidemiol 39:405–411CrossRefPubMed
5.
Zurück zum Zitat Cassir N, Papazian L, Fournier PE, Raoult D, La Scola B (2015) Insights into bacterial colonization of intensive care patients’ skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis 34:999–1004CrossRefPubMed Cassir N, Papazian L, Fournier PE, Raoult D, La Scola B (2015) Insights into bacterial colonization of intensive care patients’ skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis 34:999–1004CrossRefPubMed
6.
Zurück zum Zitat Cassir N, Thomas G, Hraiech S, Brunet J, Fournier PE, La Scola B, Papazian L (2015) Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control 43:640–643CrossRefPubMed Cassir N, Thomas G, Hraiech S, Brunet J, Fournier PE, La Scola B, Papazian L (2015) Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control 43:640–643CrossRefPubMed
7.
Zurück zum Zitat Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA (2007) Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 167:2073–2079CrossRefPubMed Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA (2007) Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 167:2073–2079CrossRefPubMed
8.
Zurück zum Zitat Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542CrossRefPubMedPubMedCentral Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M, Herwaldt LA, Weinstein RA, Sepkowitz KA, Jernigan JA, Sanogo K, Wong ES (2013) Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 368:533–542CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R, Program CDCPE, Network AD, Healthcare-Associated Infections P (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265CrossRefPubMed Huang SS, Septimus E, Kleinman K, Moody J, Hickok J, Avery TR, Lankiewicz J, Gombosev A, Terpstra L, Hartford F, Hayden MK, Jernigan JA, Weinstein RA, Fraser VJ, Haffenreffer K, Cui E, Kaganov RE, Lolans K, Perlin JB, Platt R, Program CDCPE, Network AD, Healthcare-Associated Infections P (2013) Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:2255–2265CrossRefPubMed
10.
Zurück zum Zitat Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM, Pediatric STSG (2013) Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 381:1099–1106CrossRefPubMedPubMedCentral Milstone AM, Elward A, Song X, Zerr DM, Orscheln R, Speck K, Obeng D, Reich NG, Coffin SE, Perl TM, Pediatric STSG (2013) Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 381:1099–1106CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, Wheeler AP (2015) Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 313:369–378CrossRefPubMedPubMedCentral Noto MJ, Domenico HJ, Byrne DW, Talbot T, Rice TW, Bernard GR, Wheeler AP (2015) Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 313:369–378CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec’h C, Azoulay E, Souweine B, Timsit JF, Group* OS (2017) Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Infect 74:131–141CrossRef Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec’h C, Azoulay E, Souweine B, Timsit JF, Group* OS (2017) Attributable mortality of ICU-acquired bloodstream infections: impact of the source, causative micro-organism, resistance profile and antimicrobial therapy. J Infect 74:131–141CrossRef
13.
Zurück zum Zitat La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jaureguy F, Clec’h C, Decre D, Maury E, Dreyfuss D, Denamur E, Ricard JD (2018) Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients. Intensive Care Med 44:531–533CrossRefPubMed La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jaureguy F, Clec’h C, Decre D, Maury E, Dreyfuss D, Denamur E, Ricard JD (2018) Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients. Intensive Care Med 44:531–533CrossRefPubMed
14.
Zurück zum Zitat Marolf CT, Alter R, Lyden E, Fey PD, Rupp ME (2017) Susceptibility of nosocomial staphylococcus aureus to chlorhexidine after implementation of a hospital-wide antiseptic bathing regimen. Infect Control Hosp Epidemiol 38:873–875CrossRefPubMed Marolf CT, Alter R, Lyden E, Fey PD, Rupp ME (2017) Susceptibility of nosocomial staphylococcus aureus to chlorhexidine after implementation of a hospital-wide antiseptic bathing regimen. Infect Control Hosp Epidemiol 38:873–875CrossRefPubMed
15.
Zurück zum Zitat Deeren D, Dewulf E, Verfaillie L (2016) Daily chlorhexidine bathing does not increase skin toxicity after remission induction or stem cell transplantation. Acta Clin Belg 71:379–382CrossRefPubMed Deeren D, Dewulf E, Verfaillie L (2016) Daily chlorhexidine bathing does not increase skin toxicity after remission induction or stem cell transplantation. Acta Clin Belg 71:379–382CrossRefPubMed
Metadaten
Titel
What’s new in the prevention of healthcare-associated infections using chlorhexidine gluconate-impregnated washcloths
verfasst von
Sandrine Dray
Jean-Marie Forel
Laurent Papazian
Publikationsdatum
26.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 2/2019
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-018-5354-y

Neu im Fachgebiet AINS

Nicht weniger Infektionen unter Vakuumversiegelungstherapie

Nach Ergebnissen der britisch-australischen SUNRISE-Studie scheint eine Unterdruck-Wundtherapie Infektionen bei abdominell Notoperierten nicht besser verhindern zu können als eine herkömmliche Wundversorgung.

Vergessene OP-Unterlage erst zwei Monate postoperativ entdeckt

Es sollte nie passieren, passiert aber doch: chirurgisches Material, das unbemerkt im Körper verbleibt. Im vorliegenden Fall wurde der Fremdkörper trotz seiner Größe erst nach zwei Monaten entdeckt – nachdem der Patient fast daran gestorben wäre.

Viele erhielten in der Pandemie zu früh Sauerstoff

Die Entscheidung zur Sauerstofftherapie in Notaufnahmen variierte in Italien während der Corona-Pandemie stark zwischen den einzelnen Kliniken. Oft entschieden sich Ärzte und Ärztinnen jedoch früher als nötig für eine Behandlung mit Sauerstoff.

Mehr Nierenkrebs bei regelmäßiger Einnahme von NSAR?

In der Allgemeinbevölkerung ist die wiederholte Verordnung von nichtsteroidalen Antirheumatika (NSAR) mit einem leicht erhöhten Nierenkrebsrisiko assoziiert. Dieses Ergebnis einer schwedischen Registerstudie ist allerdings mit einigen Fragezeichen zu versehen. 

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.